Cover Image
Market Research Report

Dental Implants (Dental Devices) - Global Market Analysis and Forecast Model

Published by GlobalData Product code 392617
Published Content info
Delivery time: 1-2 business days
Price
Back to Top
Dental Implants (Dental Devices) - Global Market Analysis and Forecast Model
Published: June 29, 2018 Content info:
Description

Dental Implants (Dental Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Dental therapeutic area.

Dental implants are used to replace teeth lost through trauma or poor dental health, and are used as anchors for crowns, bridges and permanent dentures. Implants are available in tapered or parallel-walled designs. Tapered implants offer improved stability in soft bone such as the posterior maxilla, while parallel-walled implants are versatile and often used in denser, harder bone.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis. Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market mode:

Currently marketed Dental Implants and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Dental Implants market revenue by segment and market outlooks from 2015-2028.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for the Dental Implants market.
  • Competitive dynamics insights and trends provided for the Dental Implants market.

Understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Zimmer Biomet, Dentsply Sirona, Straumann, Planmeca Oy, Danaher, Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope:

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the dental implants marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy:

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Dental Implants market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Dental Implants market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Dental Implants market from 2015-2028.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Table of Contents
Product Code: GDME202MM

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Dental Implants Overview

3. Products under Development

  • 3.1. Dental Implants - Pipeline Products by Stage of Development
  • 3.2. Dental Implants - Pipeline Products by Segment
  • 3.3. Dental Implants - Pipeline Products by Territory
  • 3.4. Dental Implants - Pipeline Products by Regulatory Path
  • 3.5. Dental Implants - Pipeline Products by Estimated Approval Date
  • 3.6. Dental Implants - Ongoing Clinical Trials

4. Dental Implants - Pipeline Products under Development by Companies

  • 4.1. Dental Implants Companies - Pipeline Products by Stage of Development
  • 4.2. Dental Implants - Pipeline Products by Stage of Development

5. Dental Implants Companies and Product Overview

  • 5.1. AddBio AB Company Overview
    • 5.1.1. AddBio AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Amedica Corp Company Overview
    • 5.2.1. Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Boston University Company Overview
    • 5.3.1. Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. CAMLOG Biotechnologies AG Company Overview
    • 5.4.1. CAMLOG Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Coland Holdings Limited Company Overview
    • 5.5.1. Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Face Your Face HandelsGesmbH Company Overview
    • 5.6.1. Face Your Face HandelsGesmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Interface Biologics Inc Company Overview
    • 5.7.1. Interface Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Louisiana State University Company Overview
    • 5.8.1. Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Maxillent Ltd Company Overview
    • 5.9.1. Maxillent Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Medtronic plc Company Overview
    • 5.10.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. MegaGen Implant Co Ltd Company Overview
    • 5.11.1. MegaGen Implant Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Nano Interface Technology LLC (Inactive) Company Overview
    • 5.12.1. Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Natural Dental Implants AG Company Overview
    • 5.13.1. Natural Dental Implants AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Neodent Company Overview
    • 5.14.1. Neodent Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Nobel Biocare Holding AG Company Overview
    • 5.15.1. Nobel Biocare Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Odontis Ltd (Inactive) Company Overview
    • 5.16.1. Odontis Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Omplant Ltd Company Overview
    • 5.17.1. Omplant Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Pharmaco-Kinesis Corp Company Overview
    • 5.18.1. Pharmaco-Kinesis Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Promimic AB Company Overview
    • 5.19.1. Promimic AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Silver Bullet Therapeutics, Inc. Company Overview
    • 5.20.1. Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Sinclair Pharma PLC Company Overview
    • 5.21.1. Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Straumann Holding AG Company Overview
    • 5.22.1. Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Taragenyx Ltd Company Overview
    • 5.23.1. Taragenyx Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Tissue Regeneration Systems, Inc. Company Overview
    • 5.24.1. Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. University of Melbourne Company Overview
    • 5.25.1. University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. University of Utah Company Overview
    • 5.26.1. University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Worthington Dental Group Company Overview
    • 5.27.1. Worthington Dental Group Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Zeev Implants Ltd Company Overview
    • 5.28.1. Zeev Implants Ltd Pipeline Products & Ongoing Clinical Trials Overview

6. Dental Implants- Recent Developments

  • 6.1. Feb 20, 2018: Henry Schein Reports Record Fourth Quarter and Full Year 2017 Financial Results
  • 6.2. Feb 19, 2018: Henry Schein And Its Dental Laboratory Business, Zahn Dental, To Showcase The Company's Latest Digital Solutions At Chicago Midwinter Dental Meeting And LMT Lab Day
  • 6.3. Feb 19, 2018: Elos Medtech - Year- end report for the period 1 January to 31 December, 2017
  • 6.4. Feb 15, 2018: Straumann Group Revenue Exceeds CHF 1bn, Rising 21% (16% organic), while Operating Margin Expands to 26%
  • 6.5. Feb 15, 2018: Straumann Group: Turnover Exceeds Billions and Grows by 21% in CHF (16% organic); Operating Margin Expanded to 26%
  • 6.6. Feb 15, 2018: Elos Medtech builds up a strong platform within Dental Implant Systems
  • 6.7. Feb 13, 2018: Henry Schein Denies FTC Anti-Trust Allegations
  • 6.8. Feb 12, 2018: Henry Schein Named one of the 2018 World's Most Ethical Companies by The Ethisphere Institute for the Seventh Time
  • 6.9. Feb 08, 2018: Zimmer Biomet's Rapid Recovery Program Marks Two Decades of Success in Europe
  • 6.10. Feb 08, 2018: Ivoclar Vivadent: 4th International Expert Symposium in Rome
  • 6.11. Feb 01, 2018: Neoss announce record profitability and market expansion into the Middle East and Asia
  • 6.12. Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
  • 6.13. Jan 30, 2018: Zimmer Biomet Announces Fourth Quarter and Full-Year 2017 Results
  • 6.14. Jan 30, 2018: Stryker reports 2017 results and 2018 outlook
  • 6.15. Jan 17, 2018: Donald M. Casey Jr. Appointed Chief Executive Officer of Dentsply Sirona
  • 6.16. Jan 17, 2018: Dentsply Sirona Announces the Addition of New Board Members
  • 6.17. Jan 09, 2018: Stryker provides 2017 preliminary net sales results
  • 6.18. Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
  • 6.19. Dec 19, 2017: Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer
  • 6.20. Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors
  • 6.21. Dec 01, 2017: Southern Implants North America Launches New Implant Designs
  • 6.22. Dec 01, 2017: Amedica Receives Positive Nasdaq Listing Decision
  • 6.23. Dec 01, 2017: Ivoclar Vivadent expands its Corporate Management
  • 6.24. Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
  • 6.25. Nov 14, 2017: Elos Medtech commits to the global orthopaedic market
  • 6.26. Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
  • 6.27. Nov 06, 2017: Henry Schein Reports Record Third Quarter Financial Results
  • 6.28. Nov 03, 2017: Dentsply Sirona Reports Third Quarter 2017 Results
  • 6.29. Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
  • 6.30. Nov 01, 2017: Zimmer Biomet Reports Third Quarter 2017 Financial Results
  • 6.31. Oct 31, 2017: The first patient of a total of 62 have been treated in AddBIO AB's clinical study
  • 6.32. Oct 26, 2017: Stryker reports third quarter 2017 results
  • 6.33. Oct 26, 2017: Straumann Group raises full-year revenue outlook as organic growth reaches 15% in first nine months
  • 6.34. Oct 25, 2017: Elos Medtech: Interim report 1 January - 30 September, 2017
  • 6.35. Oct 24, 2017: Orthocell receives A$2.3m R&D tax incentive refund
  • 6.36. Oct 16, 2017: Dentsply Sirona Announces Additions to Executive Leadership Team
  • 6.37. Oct 11, 2017: Henry Schein Donates More Than $18,000 In Dental Supplies To The Growing Smiles Foundation
  • 6.38. Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
  • 6.39. Oct 04, 2017: Zimmer Biomet Provides Update on Manufacturing Facilities in Guaynabo and Ponce, Puerto Rico
  • 6.40. Oct 02, 2017: Dentsply Sirona Announces Leadership Changes
  • 6.41. Sep 22, 2017: Amedica Releases First and Second Quarter 2017 Preliminary Unaudited Earnings Report and Business Update
  • 6.42. Sep 19, 2017: Sinclair Pharma: Interim Results
  • 6.43. Aug 31, 2017: AddBIO: Approval from the Swedish Medical Product Agency
  • 6.44. Aug 25, 2017: Elos Medtech Interim Report January 1 - June 30, 2017
  • 6.45. Aug 22, 2017: Medtronic Reports First Quarter Financial Results
  • 6.46. Aug 17, 2017: Straumann Group posts H1 revenue growth of 14% with further margin improvement
  • 6.47. Aug 11, 2017: Henry Schein Launches 2017 Healthy Lifestyles, Healthy Communities Program
  • 6.48. Aug 09, 2017: Dentsply Sirona Reports Second Quarter 2017 Results
  • 6.49. Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
  • 6.50. Aug 08, 2017: Henry Schein Reports Record Second Quarter Financial Results
  • 6.51. Aug 07, 2017: Henry Schein Now Accepting Applications For The Third Annual Henry Schein Cares Medal
  • 6.52. Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
  • 6.53. Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results
  • 6.54. Jul 27, 2017: Stryker reports second quarter 2017 results
  • 6.55. Jul 19, 2017: Henry Schein Launches New Medical Website
  • 6.56. Jul 11, 2017: Zimmer Biomet Announces Leadership Transition
  • 6.57. Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results
  • 6.58. Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017
  • 6.59. Jul 05, 2017: Henry Schein Supports Volunteer Endodontists Expanding Oral Health Care In Jamaica
  • 6.60. Jul 04, 2017: BIH supports eight trendsetting innovation projects for better patient care
  • 6.61. Jun 28, 2017: Zest Dental Solutions, Developer and Manufacturer of the Genuine LOCATOR, Celebrates 40th Anniversary
  • 6.62. Jun 27, 2017: Henry Schein Settles Litigation
  • 6.63. Jun 18, 2017: New Improved Design AlphaUniverse Multi Unit Abutment System
  • 6.64. Jun 13, 2017: Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility
  • 6.65. Jun 08, 2017: Amedica Releases 2016 Preliminary Earnings Report and Business Update
  • 6.66. Jun 05, 2017: FDA Pushes Back UDI Compliance Deadlines for Low-Risk Medical Devices
  • 6.67. May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
  • 6.68. May 09, 2017: Henry Schein Reports Record First Quarter Financial Results
  • 6.69. Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results
  • 6.70. Apr 27, 2017: Strong performance continues as Straumann posts 15% organic growth in Q1
  • 6.71. Apr 26, 2017: Elos Medtech Interim report, 1 January - 31 March, 2017
  • 6.72. Apr 25, 2017: Stryker reports first quarter 2017 results
  • 6.73. Apr 19, 2017: Henry Schein Announces New $750 Million Credit Facility
  • 6.74. Apr 19, 2017: Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter 148
  • 6.75. Apr 10, 2017: Henry Schein Donates More Than $80,000 In Health Supplies And Equipment To Children's Aid Society Community Health Centers In New York City
  • 6.76. Mar 30, 2017: Sinclair Pharma: Additional listing
  • 6.77. Mar 28, 2017: The iSy Implant System - An Intelligent Concept For Modern Dental Practices
  • 6.78. Mar 28, 2017: CAMLOG presents the CERALOG Ceramic Implant System
  • 6.79. Mar 22, 2017: Straumann Group presents numerous innovations at the 37th International Dental Show in Cologne
  • 6.80. Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016
  • 6.81. Mar 20, 2017: Natural Dental Implants Announces 3D Printed REPLICATE Tooth at International Dental Show in Cologne
  • 6.82. Mar 20, 2017: Straumann Group strengthens executive team to sustain dynamic growth in APAC and to lead Global People Management & Development
  • 6.83. Mar 14, 2017: LISI Medical Remmele Planning Big Lake Expansion
  • 6.84. Mar 10, 2017: Managing Director at Elos Medtech Tianjin steps down
  • 6.85. Mar 09, 2017: FDA inspection summary in TAG Medical Products
  • 6.86. Mar 03, 2017: Elos Medtech: The Nomination Committee's proposal for new Chairman and new Board Member
  • 6.87. Mar 01, 2017: Instradent/Neodent Prevails Against Nobel Biocare As Key Patent Claims Are Invalidated By Patent Trial And Appeal Board In The USA
  • 6.88. Feb 27, 2017: Amedica Announces Results of Independent Femoral Head Wear Testing

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Dental Implants - Pipeline Products by Stage of Development
  • Table 2: Dental Implants - Pipeline Products by Segment
  • Table 3: Dental Implants - Pipeline Products by Territory
  • Table 4: Dental Implants - Pipeline Products by Regulatory Path
  • Table 5: Dental Implants - Pipeline Products by Estimated Approval Date
  • Table 6: Dental Implants - Ongoing Clinical Trials
  • Table 7: Dental Implants Companies - Pipeline Products by Stage of Development
  • Table 8: Dental Implants - Pipeline Products by Stage of Development
  • Table 9: AddBio AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Boston University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: CAMLOG Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Face Your Face HandelsGesmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Interface Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Maxillent Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: MegaGen Implant Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Natural Dental Implants AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: Neodent Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Nobel Biocare Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 72: Odontis Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 75: Omplant Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 78: Pharmaco-Kinesis Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: Promimic AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 87: Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Straumann Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: Taragenyx Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 106: Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: Worthington Dental Group Pipeline Products & Ongoing Clinical Trials Overview
  • Table 118: Zeev Implants Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Glossary

List of Figures

  • Figure 1: Dental Implants - Pipeline Products by Stage of Development
  • Figure 2: Dental Implants - Pipeline Products by Segment
  • Figure 3: Dental Implants - Pipeline Products by Territory
  • Figure 4: Dental Implants - Pipeline Products by Regulatory Path
  • Figure 5: Dental Implants - Pipeline Products by Estimated Approval Date
  • Figure 6: Dental Implants - Ongoing Clinical Trials
Back to Top